LSX Nordic Congress White

 

INTERNATIONAL PARTNERING, STRATEGY & INVESTMENT FOR NORDIC LIFE SCIENCE EXECUTIVE LEADERS


6th Annual Congress



SAVE THE DATE - 10-11 October, 2023
Bella Sky, Center Blvd. 5, 2300
Copenhagen, Denmark

DOWNLOAD BROCHURE

Follow us on linkedin
LSX Nordic Congress
#LSXNordic

What is the LSX Nordic Congress?


The LSX Nordic Congress is the leading senior executive strategy, investment and partnering conference for the Nordic region.

It connects life science and healthcare industry leaders with international investment and strategic partners to further the growth, development and internationalisation of Nordic life science and healthcare innovation.

The mission is to facilitate ever greater international investment into the region, as well as foster strategic partnerships and collaboration with international healthcare stakeholders.

After four years in Stockholm, and as we return in-person in 2022, we are delighted to be hosting the 5th LSX Nordic Congress in Copenhagen, Denmark! As the hub of Medicon Valley, the crucible of Scandinavian life sciences, we can’t wait to welcome you all to Copenhagen in September!

LSX Nordic Congress

DOWNLOAD BROCHURE

1-2-1 Partnering


Transform your partnering experience. With our app-based partnering system, you can schedule, move and confirm meetings ‘on the fly’. Find new strategic partnerships, search for companies with similar interests or connect with potential clients face-to-face.

LEARN MORE

 

Nordic 121 partnering 2

Meet the 2022 Speakers


Rita Balice Gordon, CEO, Muna Therapeutics

Rita Balice Gordon

CEO
Muna Therapeutics
Kim Baden-Kristensen, CEO, Brain+

Kim Baden-Kristensen

CEO
Brain+
Anta Gkelou, Principal, Capital Strategy, Sofinnova Partners

Anta Gkelou

Principal, Capital Strategy
Sofinnova Partners
John Drakenberg Renander, CEO, Alex Therapeutics

John Drakenberg Renander

CEO
Alex Therapeutics
Giovanni Rizzo, Partner Biotech Fund, Indaco Venture Partners

Giovanni Rizzo

Venture Partner
Indaco Venture Partners
Hans Schambye, President & CEO, Galecto

Hans Schambye

President & CEO
Galecto
Adam Kostyal, SVP, Nasdaq

Adam Kostyal

SVP
Nasdaq
Jacob Falck Hansen, Partner, Lundbeckfonden BioCapital

Jacob Falck Hansen

Partner
Lundbeckfonden BioCapital
Mette Kirstine Agger, Strategic Advisor, Life Science Companies

Mette Kirstine Agger

Strategic Advisor
Life Science Companies
Jonathan Gertler, CEO, Back Bay Life Science Advisors 300x

Jonathan Gertler

CEO, Back Bay Life Science Advisors and Managing Director
BioVentures MedTech Funds
Duncan Young, Sr. Director Business Development & Licencing, AstraZeneca

Duncan Young

Sr. Director Business Development & Licencing
AstraZeneca
Pekka Simula, Partner, Innovestor Life Science

Pekka Simula

Partner
Innovestor Life Science
Nanna Luneborg

Nanna Luneborg

General Partner
Forbion
Ingrid Teigland Akay, Managing Partner, Hadean Ventures

Ingrid Teigland Akay

Managing Partner
Hadean Ventures
Matt Fujisawa, Global Head of Corporate Development, KRY-1

Matt Fujisawa

Global Head of Corporate Development
KRY
Carl Kilander, Partner, HealthCa

Carl Kilander

Partner
HealthCa

ALL SPEAKERS

400+
participants

150+
international investors & pharma

150+
c-suite company executives

2 days
1:1  partnering

30+
company showcases

2022 Sponsors


 

Platinum sponsors


Back Bay Life Science Advisors

Nasdaq

 

Local host partners


Lundbeckfonden Logo

Novo Nordisk Fonden Logo

 

BioInnovation Institute (BII) Logo

Gold sponsors


Coulter Partners

Covington 300x150

 

Mintz

Potter Clarkson

MSC Nordics

 

Willis Towers Watson

NDA Logo web_use

 

Vator securities logo

 

International Investor sponsors


Ministry of Foreign Affairs of Denmark

Vækstfonden Logo

 

Bronze sponsors


DFIN

Grand Pacific CRO Logo

Mangold Fondkommission 300x

 

DOWNLOAD BROCHURE